REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $292,646,109 | +6.3% | 10,572,475 | +2.7% | 0.06% | +13.5% |
Q2 2023 | $275,249,182 | +21.9% | 10,289,689 | -1.3% | 0.05% | +15.6% |
Q1 2023 | $225,813,473 | +6.8% | 10,425,368 | +17.5% | 0.04% | +7.1% |
Q4 2022 | $211,378,062 | +45.2% | 8,873,974 | +20.2% | 0.04% | +35.5% |
Q3 2022 | $145,557,000 | +21.1% | 7,381,179 | +19.6% | 0.03% | +29.2% |
Q2 2022 | $120,233,000 | +15.4% | 6,169,002 | +51.1% | 0.02% | +33.3% |
Q1 2022 | $104,183,000 | -8.2% | 4,083,989 | -9.5% | 0.02% | 0.0% |
Q4 2021 | $113,539,000 | -9.0% | 4,510,895 | -0.6% | 0.02% | -14.3% |
Q3 2021 | $124,815,000 | -29.5% | 4,537,102 | -18.7% | 0.02% | -27.6% |
Q2 2021 | $177,081,000 | -1.6% | 5,579,048 | +42.3% | 0.03% | -9.4% |
Q1 2021 | $179,881,000 | +1856.9% | 3,920,648 | +1588.5% | 0.03% | +1500.0% |
Q4 2020 | $9,192,000 | +29.6% | 232,191 | +13.9% | 0.00% | +100.0% |
Q3 2020 | $7,093,000 | -20.5% | 203,839 | -27.9% | 0.00% | -50.0% |
Q2 2020 | $8,925,000 | +21.0% | 282,741 | -16.0% | 0.00% | 0.0% |
Q1 2020 | $7,376,000 | – | 336,665 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,524,031 | $175,333,000 | 30.61% |
TRV GP IV, LLC | 1,419,900 | $45,068,000 | 21.46% |
Ponoi II Management, LLC | 685,011 | $21,742,000 | 17.62% |
Column Group LLC | 3,347,245 | $106,242,000 | 15.04% |
Ponoi Management, LLC | 685,011 | $21,742,000 | 12.08% |
Boxer Capital, LLC | 3,484,264 | $110,591,000 | 3.90% |
Cormorant Asset Management, LP | 3,338,166 | $105,953,000 | 3.60% |
BVF INC/IL | 2,485,049 | $78,875,000 | 2.96% |
Casdin Capital, LLC | 2,305,000 | $73,161,000 | 1.86% |
Burrage Capital Management LLC | 50,000 | $1,587,000 | 1.59% |